AstraZeneca Has Lost The Lead In Race For Coronavirus Vaccine, Says SVB Leerink

AstraZeneca plc's prospects at being the first mover in the competition to develop a coronavirus vaccine have dimmed, according to an analyst at SVB Leerink.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.